Experience in the treatment of prostatic carcinoma with cyproterone acetate.
D015068:17-Ketosteroids / Q000652:urine; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000726:Androgen Antagonists; D002277:Carcinoma / Q000188:drug therapy* / Q000378:metabolism; D003534:Cyproterone / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006914:Hydroxysteroids / Q000652:urine; D008297:Male; D008875:Middle Aged; D010146:Pain; D011245:Pregnadienes / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism
D015068:17-Ketosteroids; D000726:Androgen Antagonists; D006914:Hydroxysteroids; D011245:Pregnadienes; D003534:Cyproterone; D000469:Alkaline Phosphatase